Temporal activity of plasminogen activators and matrix metalloproteinases during cutaneous wound repair

被引:50
|
作者
Arumugam, S
Jang, YC
Chen-Jensen, C
Gibran, NS
Isik, FF
机构
[1] Vet Adm Puget Sound Hlth Care Syst, Dept Surg, Seattle, WA 98108 USA
[2] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA
[3] Univ Illinois, Coll Med, Chicago, IL USA
关键词
D O I
10.1067/msy.1999.98254
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Response to tissue injury begins with the deposition of a fibrin-rich clot or the provisional matrix. The provisional matrix consists of plasma-borne matrix molecules that serve as scaffolding for the ensuing migration of cells. During wound repair multiple cell types must migrate through the clot-matrix scaffolding: The migration of these cells through the matrix is dependent on the activity of the fibrinolytic and proteolytic systems, which include the plasminogen activator (PA) system and matrix metalloproteinases (MMP). The aim of this study was to better understand the temporal activity of these enzymes during normal wound repair. Methods. We used the murine excisional wound model and extracted proteins under nonreducing conditions, With use Of gelatin and casein zymography, we determined the activity of the MMPs during the course of wound repair In addition, we quantified the activity of MMP-2 and MMP-9 by a standardized assay. Plasminogen zymograms were used to detect urokinase PA and tissue PA activity. Western blots were used to detect the natural inhibitor of PAs, plasminogen activator inhibitor type 1. Results. Our results demonstrate the temporal activity of MMP-2, MMP-3, MMP-7, and MMP-9 during the course of normal dermal repair. The activity of urokinase PA and tissue PA were also determined; it preceded the activity of the MMPs. Conclusions. We demonstrate the temporal activity of the 2 protease families, MMPs and PAs, in the normal process of cutaneous wound healing.
引用
收藏
页码:587 / 593
页数:7
相关论文
共 50 条
  • [1] Plasminogen activators and matrix metalloproteinases during arterial remodeling
    Plekhanova, O. S.
    Solomatina, M. A.
    Menshikov, M. Yu.
    Bashtrykov, P. P.
    Korshunov, V. A.
    Berk, B. S.
    Tkachuk, V. A.
    Parfyonova, Ye. V.
    [J]. KARDIOLOGIYA, 2006, 46 (09) : 47 - 56
  • [2] Plasminogen activators and matrix metalloproteinases in angiogenesis
    Mignatti, P
    Rifkin, DB
    [J]. ENZYME & PROTEIN, 1996, 49 (1-3) : 117 - 137
  • [4] Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing
    Moses, MA
    Marikovsky, M
    Harper, JW
    Vogt, P
    Eriksson, E
    Klagsbrun, M
    Langer, R
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, 60 (03) : 379 - 386
  • [5] EXTRACELLULAR-MATRIX REMODELING BY METALLOPROTEINASES AND PLASMINOGEN ACTIVATORS
    MIGNATTI, P
    [J]. KIDNEY INTERNATIONAL, 1995, 47 : S12 - S14
  • [6] A paradoxical role of plasminogen activators and matrix metalloproteinases in matrix remodeling during hypertension induced hypertrophy
    Heymans, RBS
    Lupu, F
    Collen, D
    Carmeliet, P
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 : S190 - S190
  • [7] Matrix metalloproteinases and epidermal wound repair
    Vera L. Martins
    Matthew Caley
    Edel A. O’Toole
    [J]. Cell and Tissue Research, 2013, 351 : 255 - 268
  • [8] Matrix metalloproteinases and epidermal wound repair
    Martins, Vera L.
    Caley, Matthew
    O'Toole, Edel A.
    [J]. CELL AND TISSUE RESEARCH, 2013, 351 (02) : 255 - 268
  • [9] Matrix metalloproteinases in wound repair (Review)
    Ravanti, L
    Kähäri, VM
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2000, 6 (04) : 391 - 407
  • [10] Plasminogen activators, matrix metalloproteinases, and their inhibitors in implanted vascular prostheses
    Urayama, H
    Katada, S
    Kasashima, F
    Tanaka, Y
    Kawasuji, K
    Watanabe, Y
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2000, 20 (06) : 501 - 507